David W. Barry

3.7k total citations · 1 hit paper
47 papers, 3.1k citations indexed

About

David W. Barry is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, David W. Barry has authored 47 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 18 papers in Immunology and 13 papers in Infectious Diseases. Recurrent topics in David W. Barry's work include Herpesvirus Infections and Treatments (13 papers), Influenza Virus Research Studies (10 papers) and HIV/AIDS drug development and treatment (8 papers). David W. Barry is often cited by papers focused on Herpesvirus Infections and Treatments (13 papers), Influenza Virus Research Studies (10 papers) and HIV/AIDS drug development and treatment (8 papers). David W. Barry collaborates with scholars based in United States, United Kingdom and Thailand. David W. Barry's co-authors include P A Furman, Sandra Nusinoff Lehrman, M H St Clair, S Broder, Dani P. Bolognesi, Robert C. Gallo, Kent J. Weinhold, Hiroaki Mitsuya, C. McLaren and Ronald E. Mayner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

David W. Barry

45 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.

1985 1.5k citations Hiroaki Mitsuya, Kent J. Weinhold et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David W. Barry United States	23	1.4k	1.3k	1.1k	626	609	47	3.1k
C. McLaren United States	26	1.4k 1.0×	1.6k 1.2×	1.1k 1.0×	540 0.9×	330 0.5×	69	2.9k
Sandra Nusinoff Lehrman United States	17	2.8k 1.9×	1.5k 1.1×	2.2k 2.0×	542 0.9×	1.0k 1.7×	21	4.3k
Martin L. Bryant United States	28	1.0k 0.7×	1.3k 0.9×	1.0k 0.9×	596 1.0×	1.0k 1.7×	48	3.2k
Bo Öberg Sweden	28	1.2k 0.8×	1.1k 0.8×	745 0.7×	234 0.4×	878 1.4×	76	2.8k
Sigvard Olofsson Sweden	39	921 0.6×	2.1k 1.5×	936 0.8×	1.1k 1.8×	1.6k 2.6×	123	4.2k
Dannie H. King United States	6	1.7k 1.2×	997 0.7×	1.3k 1.2×	223 0.4×	284 0.5×	8	2.7k
T. C. Merigan United States	35	1.0k 0.7×	1.1k 0.9×	952 0.9×	1.2k 2.0×	473 0.8×	89	3.7k
D. D. Richman United States	26	1.6k 1.1×	1.1k 0.8×	2.0k 1.8×	677 1.1×	527 0.9×	44	3.2k
Syed Zaki Salahuddin United States	8	1.4k 0.9×	886 0.7×	2.0k 1.8×	1.8k 2.8×	383 0.6×	9	3.6k
Prem S. Sarin United States	33	1.1k 0.8×	732 0.5×	1.3k 1.1×	2.3k 3.7×	1.9k 3.1×	87	5.6k

Countries citing papers authored by David W. Barry

Since Specialization

Citations

This map shows the geographic impact of David W. Barry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Barry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Barry more than expected).

Fields of papers citing papers by David W. Barry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Barry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Barry. The network helps show where David W. Barry may publish in the future.

Co-authorship network of co-authors of David W. Barry

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Barry. A scholar is included among the top collaborators of David W. Barry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Barry. David W. Barry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barry, David W. & Michael F. Vaezi. (2010). Laryngopharyngeal reflux: More questions than answers. Cleveland Clinic Journal of Medicine. 77(5). 327–334. 74 indexed citations

Rousseau, Franck, Charles Wakeford, Herve Momméja-Marin, et al.. (2003). Prospective Randomized Trial of Emtricitabine versus Lamivudine Short‐Term Monotherapy in Human Immunodeficiency Virus–Infected Patients. The Journal of Infectious Diseases. 188(11). 1652–1658. 54 indexed citations

Barry, David W. & Linda M. Distlerath. (2000). History and Accomplishments of the Inter-Company Collaboration for Aids Drug Development. Drug Information Journal. 34(3). 741–752. 3 indexed citations

Clair, Marty St., Kevin N. Pennington, James F. Rooney, & David W. Barry. (1995). Rapid Screening of Antiretroviral Combinations. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 10(Supplement). S28–S28. 28 indexed citations

Clair, M H St, Kevin N. Pennington, John P. Rooney, & David W. Barry. (1995). In vitro comparison of selected triple-drug combinations for suppression of HIV-1 replication: the Inter-Company Collaboration Protocol.. PubMed. 10 Suppl 2. S83–91. 13 indexed citations

LaFon, Stephen W., Sandra Nusinoff Lehrman, & David W. Barry. (1988). Prophylactically Administered Retrovir(R) in Health Care Workers Potentially Exposed to the Human Immunodeficiency Virus. The Journal of Infectious Diseases. 158(2). 503–503. 14 indexed citations

Parks, Wade P., Elizabeth S. Parks, Margaret A. Fischl, et al.. (1988). HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trail.. PubMed. 1(2). 125–30. 16 indexed citations

Ellis, Mark, Paul M. Keller, James A. Fyfe, et al.. (1987). Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Antimicrobial Agents and Chemotherapy. 31(7). 1117–1125. 73 indexed citations

Lehrman, Sandra Nusinoff, Edgar L. Hill, James F. Rooney, et al.. (1986). Extended acyclovir therapy for herpes genitalis: changes in virus sensitivity and strain variation. Journal of Antimicrobial Chemotherapy. 18(Supplement_B). 85–94. 22 indexed citations

10.

Martin, J L, Mark Ellis, Paul M. Keller, et al.. (1985). Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrobial Agents and Chemotherapy. 28(2). 181–187. 53 indexed citations

11.

Mitsuya, Hiroaki, Kent J. Weinhold, P A Furman, et al.. (1985). 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.. Proceedings of the National Academy of Sciences. 82(20). 7096–7100. 1508 indexed citations breakdown →

12.

Ellis, Mark, et al.. (1983). Virus resistance in clinical practice. Journal of Antimicrobial Chemotherapy. 12(suppl B). 137–152. 52 indexed citations

13.

Barry, David W., Ronald E. Mayner, H. Donald Hochstein, et al.. (1976). COMPARATIVE TRIAL OF INFLUENZA VACCINES. American Journal of Epidemiology. 104(1). 47–59. 56 indexed citations

14.

Barry, David W., et al.. (1976). Acute and Chronic Infection of Human Lymphoblastoid Cell Lines with Measles Virus. The Journal of Immunology. 116(1). 89–98. 27 indexed citations

15.

Barry, David W., et al.. (1975). Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes.. The Journal of Experimental Medicine. 142(3). 773–784. 107 indexed citations

16.

Dunnick, N. Reed, et al.. (1975). Isolation of Foamy Virus from Rhesus, African Green andCynomolgus Monkey Leukocytes. Journal of Medical Primatology. 4(5). 287–295. 9 indexed citations

17.

Sullivan, John L., et al.. (1975). Inhibition of Lymphocyte Stimulation by Measles Virus. The Journal of Immunology. 114(5). 1458–1461. 58 indexed citations

18.

Brown, Elaine, et al.. (1975). Determination of the viral particle content of influenza vaccines by electron microscopy. Journal of Biological Standardization. 3(3). 281–289. 9 indexed citations

19.

Casals, J., Sonja M. Buckley, & David W. Barry. (1973). Resistance to Arbovirus Challenge in Mice Immediately After Vaccination. Applied Microbiology. 25(5). 755–762. 10 indexed citations

20.

Barry, David W., et al.. (1955). The television-radio audience and religion. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact